Alma Fulurija

Get notifications in MyBN when activity occurs.
Alma Fulurija
Head Immunology and Translational Research / Ondek
Dr Alma Fulurija is an Australian graduate from Perth, attracted back from Switzerland after a successful career in the fields of novel vaccines and immunology. She has a wide variety of experience in vaccine development and immunotherapy including most recently with Cytos Biotechnology, voted Switzerland’s most exciting new biotechnology startup float in 2005. She has also worked at the WHO Centre for Neonatal Immunology and Vaccinology in Geneva and has collaborated with Novartis and Pfizer on a number of projects. Dr Fulurija’s key expertise lies in in vivo pre-clinical models, as well as clinical and regulatory requirements for Phase I/II clinical trials. Dr Fulurija is Ondek’s Head of Immunology and Translational Research and also holds an Adjunct Senior Lecturer position at the University of Western Australia


Subscription Options